Literature DB >> 9838563

Effects of rifampin on cyclosporine disposition in kidney recipients with tuberculosis.

Y H Kim1, Y R Yoon, Y W Kim, J G Shin, I J Cha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9838563     DOI： 10.1016/s0041-1345(98)01139-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  American Society of Nephrology Quiz and Questionnaire 2013: transplantation.

Authors:  Michelle A Josephson; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

Review 2.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.

Authors:  Spencer Y Ling; Robert B Huizinga; Patrick R Mayo; Richard Larouche; Derrick G Freitag; Launa J Aspeslet; Robert T Foster
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

Review 4.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

Review 5.  Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-02-15       Impact factor: 3.944

6.  A case series of gastrointestinal tuberculosis in renal transplant patients.

Authors:  Pedro Azevedo; Cristina Freitas; Hugo Silva; Pedro Aguiar; Pedro Farrajota; Manuela Almeida; Sofia Pedroso; La Salete Martins; Leonídio Dias; José Ramón Vizcaíno; António Castro Henriques; António Cabrita
Journal:  Case Rep Nephrol       Date:  2013-02-24

7.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.